SAN ANTONIO -- Active monitoring for low-risk ductal carcinoma in situ (DCIS) did not lead to a higher rate of ipsilateral invasive cancer versus guideline-recommended treatment, the randomized COMET trial...

The non-small cell lung cancer (NSCLC) drug osimertinib (Tagrisso) was associated with an increased risk of therapy-related cardiovascular (CV) events compared with older EGFR inhibitors, a retrospective cohort study from...

New questions about the landmark trial that launched the antiplatelet drug ticagrelor worldwide are being raised after an investigation uncovered more information about how the PLATO study was conducted.Peter Doshi,...

Orlando-area physician Thomas Wentzell, MD, was arrested and confessed to killing his wife, according to local police. (WFTV9) Twenty lawsuits were filed alleging sexual abuse of psychiatric patients at Four...

Success in personal finance and reaching financial freedom is not complicated. But that does not mean it is necessarily easy -- especially for doctors. Healthcare professionals actually have some significant...

One of the most meaningful shifts in the cancer treatment landscape has been the move toward therapies that not only fight the disease, but also empower patients and healthcare professionals...

Share on PinterestThe 12-3-30 treadmill challenge is trending on TikTok, but can the viral workout really help you lose weight? M_a_y_a/Getty ImagesTikTok users claim the 12-3-30 treadmill challenge can help...

Postmarketing data on obeticholic acid (Ocaliva) identified a risk for serious liver injury in primary biliary cholangitis (PBC) patients without cirrhosis, the FDA said in a safety communication on Thursday....

TOPLINE:From 2008 to 2020, US schools reported significant increases in emotional/mental health education (from 83.8% to 89.8%) and suicide prevention programs (from 70.1% to 81.8%), while substance use prevention declined...

Califf is FDA commissioner. Sokolowska is an FDA deputy center director specializing in substance use and behavioral health. As of 2023, more than 5 million people ages 12 or older...

The HER2-low and HER2-ultralow breast cancer subtype designations have led to a changed landscape in HER2-directed therapies, as well as a desire for more sensitive assays that may better quantify...

The government has said the first victims of the infected blood scandal will receive final compensation payments this week. Ten people have been offered a settlement worth over £13m in...

SAN DIEGO -- A significant overall survival (OS) benefit with belantamab mafodotin (belantamab; Blenrep) in a phase III trial of relapsed or refractory multiple myeloma should smooth the way for...

The idea of requiring site-neutral payments in Medicare -- in which providers would be reimbursed at the same rate for performing the same service, regardless of where it's performed --...

Note that some links may require registration or subscription. "Wanted" posters of healthcare CEOs were put up in New York City in the wake of the killing of UnitedHealthcare CEO...

The mystery flu-like illness that killed dozens of people in southwest Congo in recent weeks might be malaria, according to results from laboratory samples of infected people, authorities said Wednesday....

Cardiologist Daniel West, MD, had practiced at Trinity Health Muskegon Hospital, Muskegon, Mich., since he finished medical school. His mother worked at the Michigan hospital as a lab technician, and...

TOPLINE:Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) and fenofibrates are associated with a reduced risk for diabetic macular edema (DME) in patients with type 2 diabetes, while calcium channel blockers...

During the first congress of the Belgian College of General Practitioners, held on November 15 and 16 in Namur, Belgium, a workshop tackled the question, "What is the fair price...

The question may seem simple: Could paying for weight loss medications — especially the pricey glucagon-like peptide 1 receptor agonists (GLP-1s), tirzepatide (Zepbound) and semaglutide (Wegovy) — be more cost-effective...